EUVIMEDEUVIMED entdecken
Open Access

SNSP113 (PAAG) improves mucociliary transport and lung pathology in the Scnn1b-Tg murine model of CF lung disease

Elex S Harris, Lea Novak, Courtney M Fernandez-Petty, Natalie R Lindgren, Shenda M Baker, Susan E Birket, Steven M Rowe

Journal of Cystic Fibrosis · 2023

DOI: 10.1016/j.jcf.2023.08.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2023. Verfasst von Elex S Harris und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gregory Fleming James Cystic Fibrosis Research Center, Univ. of Alabama at Birmingham, Birmingham, AL, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pregnancy-Associated alpha 2-Macroglobulins, Airway Obstruction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mucus stasis, a hallmark of muco-obstructive disease, results from impaired mucociliary transport and leads to lung function decline and chronic infection. Although therapeutics that target mucus stasis in the airway, such as hypertonic saline or rhDNAse, show some therapeutic benefit, they do not address the underlying electrostatic defect apparent in mucins in CF and related conditions. We have previously shown poly (acetyl, arginyl) glucosamine (PAAG, developed as SNSP113), a soluble, cationic polymer, significantly improves mucociliary transport in a rat model of CF by normalizing the charge defects of CF mucin. Here, we report efficacy in the CFTR-sufficient, ENaC hyperactive, Scnn1b-Tg mouse model that develops airway muco-obstruction due to sodium hyperabsorption and airway dehydration. METHODS: Scnn1b-Tg mice were treated with either 250 µg/mL SNSP113 or vehicle control (1.38% glycerol in PBS) via nebulization once daily for 7 days and then euthanized for analysis. Micro-Optical Coherence Tomography-based evaluation of excised mouse trachea was used to determine the effect on the functional microanatomy. Tissue analysis was performed by routine histopathology. RESULTS: Nebulized treatment of SNSP113 significantly improved mucociliary transport in the airways of Scnn1b-Tg mice, without altering the airway surface or periciliary liquid layer. In addition, SNSP113 significantly reversed epithelial hypertrophy and goblet cell metaplasia. Finally, SNSP113 significantly ameliorated eosinophilic crystalline pneumonia and lung consolidation in addition to inflammatory macrophage influx in this model. CONCLUSION: Overall, this study extends the efficacy of SNSP113 as a potential therapeutic to alleviate mucus stasis in muco-obstructive diseases in CF and potentially in related conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisPregnancy-Associated alpha 2-MacroglobulinsAirway ObstructionFemalePregnancyMiceAnimalsRatsMucociliary ClearanceMice, TransgenicDisease Models, AnimalMice, Inbred CFTRLungEpithelial Sodium Channels

Stichwörter der Autor:innen

Cystic fibrosisMicro-optical coherence tomographyMuco-obstructive diseaseMucociliary transportMucolyticPAAGSNSP113Scnn1b-Tg mouse

Substanzen

Pregnancy-Associated alpha 2-MacroglobulinsScnn1b protein, mouseEpithelial Sodium Channels

Autor:innen und Institutionen

  • Gregory Fleming James Cystic Fibrosis Research Center, Univ. of Alabama at Birmingham, Birmingham, AL, USA.
  • Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Synspira Therapeutics, Inc., Framingham, MA, USA.
  • Gregory Fleming James Cystic Fibrosis Research Center, Univ. of Alabama at Birmingham, Birmingham, AL, USA; Departments of Pediatrics, and Cell Developmental and Integrative Biology, University of Alabama at Birmingham,…
  • Gregory Fleming James Cystic Fibrosis Research Center, Univ. of Alabama at Birmingham, Birmingham, AL, USA; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Departments of Pediatrics, an…

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute
  • Cystic Fibrosis Foundation
  • National Institutes of Health

Zitieren

APA

Harris, E. S., Novak, L., Fernandez-Petty, C. M., Lindgren, N. R., Baker, S. M., Birket, S. E., & Rowe, S. M. (2023). SNSP113 (PAAG) improves mucociliary transport and lung pathology in the Scnn1b-Tg murine model of CF lung disease. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2023.08.011

Vancouver

Harris ES, Novak L, Fernandez-Petty CM, Lindgren NR, Baker SM, Birket SE, et al. SNSP113 (PAAG) improves mucociliary transport and lung pathology in the Scnn1b-Tg murine model of CF lung disease. Journal of Cystic Fibrosis. 2023. doi:10.1016/j.jcf.2023.08.011

BibTeX
@article{Harris2023,
  author = {Harris, Elex S and Novak, Lea and Fernandez-Petty, Courtney M and Lindgren, Natalie R and Baker, Shenda M and Birket, Susan E and Rowe, Steven M},
  title = {SNSP113 (PAAG) improves mucociliary transport and lung pathology in the Scnn1b-Tg murine model of CF lung disease},
  journal = {Journal of Cystic Fibrosis},
  year = {2023},
  doi = {10.1016/j.jcf.2023.08.011}
}
Kostenlos starten →